{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:07:50Z","timestamp":1791925670408,"version":"4.3.4"},"reference-count":114,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T00:00:00Z","timestamp":1714780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG067552"],"award-info":[{"award-number":["AG067552"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY011373"],"award-info":[{"award-number":["EY011373"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jlr.2024.100555","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T16:17:43Z","timestamp":1715012263000},"page":"100555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-640X","authenticated-orcid":false,"given":"Natalia","family":"Mast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8654-5493","authenticated-orcid":false,"given":"Makaya","family":"Butts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-6232","authenticated-orcid":false,"given":"Irina A.","family":"Pikuleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jlr.2024.100555_bib1","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1073\/pnas.96.13.7238","article-title":"cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain","volume":"96","author":"Lund","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib2","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/cne.21605","article-title":"Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain","volume":"507","author":"Ramirez","year":"2008","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.jlr.2024.100555_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/02713680701231857","article-title":"Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina","volume":"32","author":"Bretillon","year":"2007","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jlr.2024.100555_bib4","article-title":"Spatial distribution of the pathways of cholesterol homeostasis in human retina","volume":"7","author":"Zheng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100555_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0022-2275(20)32188-X","article-title":"Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation","volume":"39","author":"Bjorkhem","year":"1998","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib6","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover","volume":"278","author":"Lund","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib7","first-page":"37004","article-title":"From brain to bile. Evidence that conjugation and omega-hydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans","volume":"276","author":"Bjorkhem","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib8","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1146\/annurev.biochem.78.072407.103859","article-title":"Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain","volume":"78","author":"Russell","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jlr.2024.100555_bib9","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1074\/jbc.M113.532846","article-title":"Pharmacologic stimulation of cytochrome P450 46A1 and cerebral cholesterol turnover in mice","volume":"289","author":"Mast","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/hum.2016.017","article-title":"Gene therapy strategies for Alzheimer's disease: an overview","volume":"27","author":"Alves","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jlr.2024.100555_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.696778","article-title":"Cholesterol hydroxylating cytochrome P450 46A1: from mechanisms of action to clinical applications","volume":"13","author":"Pikuleva","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib12","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1021\/acs.jmedchem.1c00864","article-title":"Discovery of soticlestat, a potent and selective inhibitor for cholesterol 24-hydroxylase (CH24H)","volume":"64","author":"Koike","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175726","article-title":"The potential of CYP46A1 as a novel therapeutic target for neurological disorders: an updated review of mechanisms","volume":"949","author":"Alavi","year":"2023","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.jlr.2024.100555_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106646","article-title":"A\u00a0phase 1b\/2a study of soticlestat as adjunctive therapy in participants with developmental and\/or epileptic encephalopathies","volume":"174","author":"Halford","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jlr.2024.100555_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109173","article-title":"Efficacy, safety, and tolerability of soticlestat as adjunctive therapy for the treatment of seizures in patients with Dup15q syndrome or CDKL5 deficiency disorder in an open-label signal-finding phase II study (ARCADE)","volume":"142","author":"Demarest","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jlr.2024.100555_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13195-022-01151-z","article-title":"CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease","volume":"14","author":"Lerner","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.jlr.2024.100555_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/mt.2009.175","article-title":"Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease","volume":"18","author":"Hudry","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jlr.2024.100555_bib18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/brain\/awv384","article-title":"CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease","volume":"139","author":"Boussicault","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2024.100555_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neuropharm.2017.06.026","article-title":"Cholesterol-metabolizing enzyme cytochrome P450 46A1 as a pharmacologic target for Alzheimer's disease","volume":"123","author":"Mast","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jlr.2024.100555_bib20","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/brain\/awz174","article-title":"CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease","volume":"142","author":"Kacher","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2024.100555_bib21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00401-019-02019-7","article-title":"Restoring brain cholesterol turnover improves autophagy and has therapeutic potential in mouse models of spinocerebellar ataxia","volume":"138","author":"Nobrega","year":"2019","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jlr.2024.100555_bib22","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948143","article-title":"NPC1 enables cholesterol mobilization during long-term potentiation that can be restored in Niemann-Pick disease type C by CYP46A1 activation","volume":"20","author":"Mitroi","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jlr.2024.100555_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s13311-019-00737-0","article-title":"CYP46A1 activation by efavirenz leads to behavioral improvement without significant changes in amyloid plaque load in the brain of 5XFAD mice","volume":"16","author":"Petrov","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jlr.2024.100555_bib24","article-title":"Restoring neuronal cholesterol efficiently rescues ALS mouse model","volume":"30","author":"Piguet","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jlr.2024.100555_bib25","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201910924","article-title":"Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma","volume":"12","author":"Han","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jlr.2024.100555_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-021-01162-1","article-title":"Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice","volume":"9","author":"Ali","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jlr.2024.100555_bib27","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/epi.17062","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice","volume":"62","author":"Hawkins","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.jlr.2024.100555_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109310","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, modifies acute seizure burden and chronic epilepsy-related behavioral deficits following Theiler's virus infection in mice","volume":"222","author":"Barker-Haliski","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jlr.2024.100555_bib29","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1093\/hmg\/ddv268","article-title":"Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology","volume":"24","author":"Burlot","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jlr.2024.100555_bib30","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.pharep.2017.04.018","article-title":"Possible anti-depressant effect of efavirenz and pro-depressive-like effect of voriconazole in specified doses in various experimental models of depression in mice","volume":"69","author":"Patel","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jlr.2024.100555_bib31","article-title":"Efavirenz restored NMDA receptor dysfunction and inhibited epileptic seizures in GluN2A\/Grin2a mutant mice","volume":"17","author":"Zhao","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib32","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/epi.17232","article-title":"Anticonvulsive properties of soticlestat, a novel cholesterol 24-hydroxylase inhibitor","volume":"63","author":"Nishi","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.jlr.2024.100555_bib33","first-page":"159","article-title":"Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases","volume":"1","author":"Pikuleva","year":"2021","journal-title":"Explor. Neuroprotective Ther."},{"key":"10.1016\/j.jlr.2024.100555_bib34","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1096\/fj.201900092R","article-title":"The key genes, phosphoproteins, processes, and pathways affected by efavirenz-activated CYP46A1 in the amyloid-decreasing paradigm of efavirenz treatment","volume":"33","author":"Petrov","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.jlr.2024.100555_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa043","article-title":"Brain sterol flux mediated by cytochrome P450 46A1 affects membrane properties and membrane-dependent processes","volume":"2","author":"Petrov","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.jlr.2024.100555_bib36","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s13311-021-01079-6","article-title":"Brain acetyl-CoA production and phosphorylation of cytoskeletal proteins are targets of CYP46A1 activity modulation and altered sterol flux","volume":"18","author":"Mast","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jlr.2024.100555_bib37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.biochi.2018.07.019","article-title":"CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: analysis of lipid raft content","volume":"153","author":"Boussicault","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.jlr.2024.100555_bib38","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.3390\/ijms23147669","article-title":"Increased acetylcholine levels and other brain effects in 5XFAD mice after treatment with 8,14-dihydroxy metabolite of efavirenz","volume":"23","author":"Mast","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2010.09.028","article-title":"Enzymes of the mevalonate pathway of isoprenoid biosynthesis","volume":"505","author":"Miziorko","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jlr.2024.100555_bib40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.yexcr.2017.02.034","article-title":"The mevalonate pathway in neurons: it's not just about cholesterol","volume":"360","author":"Moutinho","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jlr.2024.100555_bib41","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1073\/pnas.0600316103","article-title":"Brain cholesterol turnover required for geranylgeraniol production and learning in mice","volume":"103","author":"Kotti","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib42","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","article-title":"The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors","volume":"33","author":"Paul","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.568641","article-title":"Effects of CYP46A1 inhibition on long-term-depression in hippocampal slices ex\u00a0vivo and 24S-hydroxycholesterol levels in mice in\u00a0vivo","volume":"13","author":"Popiolek","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib44","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/brain\/awv166","article-title":"CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease","volume":"138","author":"Djelti","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jlr.2024.100555_bib45","doi-asserted-by":"crossref","first-page":"11394","DOI":"10.1073\/pnas.0805556105","article-title":"Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation","volume":"105","author":"Kotti","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib46","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fnmol.2017.00211","article-title":"Neuronal cholesterol accumulation induced by Cyp46a1 down-regulation in mouse hippocampus disrupts brain lipid homeostasis","volume":"10","author":"Ayciriex","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2009.05917.x","article-title":"Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats","volume":"109","author":"Nieweg","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jlr.2024.100555_bib48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100555_bib49","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1152\/jn.00890.2015","article-title":"Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices","volume":"115","author":"Sun","year":"2016","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.jlr.2024.100555_bib50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.plipres.2016.09.002","article-title":"Oxysterols: from cholesterol metabolites to key mediators","volume":"64","author":"Mutemberezi","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bph.15969","article-title":"Identification and characterization of select oxysterols as ligands for GPR17","volume":"180","author":"Harrington","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100555_bib52","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1073\/pnas.0700899104","article-title":"Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig","volume":"104","author":"Radhakrishnan","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib53","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib54","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0042-6989(01)00146-8","article-title":"Retinal degeneration mutants in the mouse","volume":"42","author":"Chang","year":"2002","journal-title":"Vis. Res."},{"key":"10.1016\/j.jlr.2024.100555_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.902254","article-title":"Low-dose anti-HIV drug efavirenz mitigates retinal vascular lesions in a mouse model of Alzheimer's disease","volume":"13","author":"El-Darzi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jlr.2024.100555_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa180","article-title":"CYP46A1-dependent and independent effects of efavirenz treatment","volume":"2","author":"Mast","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.jlr.2024.100555_bib57","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00018-023-05056-4","article-title":"APOB100 transgenic mice exemplify how the systemic circulation content may affect the retina without altering retinal cholesterol input","volume":"81","author":"El-Darzi","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib58","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1194\/jlr.S120001025","article-title":"Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures","volume":"61","author":"Liebisch","year":"2020","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib59","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1167\/iovs.10-6021","article-title":"Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain","volume":"52","author":"Mast","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib60","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41596-019-0128-8","article-title":"Protocol update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)","volume":"14","author":"Mi","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jlr.2024.100555_bib61","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jlr.2024.100555_bib62","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41596-022-00710-w","article-title":"Using MetaboAnalyst 5.0 for LC\u2013HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data","volume":"17","author":"Pang","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jlr.2024.100555_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187168","article-title":"Transcriptional and post-translational changes in the brain of mice deficient in cholesterol removal mediated by cytochrome P450 46A1 (CYP46A1)","volume":"12","author":"Mast","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100555_bib64","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s12035-014-8828-0","article-title":"Cholesterol 24S-hydroxylase overexpression inhibits the liver X receptor (LXR) pathway by activating small guanosine triphosphate-binding proteins (sGTPases) in neuronal cells","volume":"51","author":"Moutinho","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jlr.2024.100555_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-binding proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jlr.2024.100555_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009798","article-title":"Identification of Arhgef12 and Prkci as genetic modifiers of retinal dysplasia in the Crb1rd8 mouse model","volume":"18","author":"Weatherly","year":"2022","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jlr.2024.100555_bib67","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s12031-022-01972-5","article-title":"Associations of ARHGAP26 polymorphisms with Alzheimer's disease and cardiovascular disease","volume":"72","author":"Wang","year":"2022","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib68","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1073\/pnas.92.22.10282","article-title":"Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family","volume":"92","author":"Chuang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib69","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/acs.chemrev.7b00181","article-title":"Lysine acetylation goes global: from epigenetics to metabolism and therapeutics","volume":"118","author":"Ali","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jlr.2024.100555_bib70","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrn3427","article-title":"Histone acetylation: molecular mnemonics on the chromatin","volume":"14","author":"Gr\u00e4ff","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib71","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.bbamcr.2013.12.016","article-title":"Regulation of histone modifying enzymes by the ubiquitin-proteasome system","volume":"1843","author":"Zou","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2024.100555_bib72","doi-asserted-by":"crossref","first-page":"20140","DOI":"10.1074\/jbc.M600225200","article-title":"Cloning and characterization of mouse lung-type acyl-CoA:lysophosphatidylcholine acyltransferase 1 (LPCAT1). Expression in alveolar type II cells and possible involvement in surfactant production","volume":"281","author":"Nakanishi","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101470","article-title":"Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity","volume":"298","author":"Valentine","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib74","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1073\/pnas.0604946103","article-title":"Identification and characterization of a lysophosphatidylcholine acyltransferase in alveolar type II cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-physiol-020518-114444","article-title":"Phospholipid remodeling in physiology and disease","volume":"81","author":"Wang","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jlr.2024.100555_bib76","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pharep.2015.12.008","article-title":"Regulation of sphingomyelin metabolism","volume":"68","author":"Bienias","year":"2016","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.jlr.2024.100555_bib77","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.gene.2004.07.042","article-title":"Identification and expression of a mouse muscle-specific CTL1 gene","volume":"341","author":"Yuan","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.jlr.2024.100555_bib78","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1096\/fj.08-121491","article-title":"The solute carrier 44A1 is a mitochondrial protein and mediates choline transport","volume":"23","author":"Michel","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.jlr.2024.100555_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100604","article-title":"Choline transporter-like proteins 1 and 2 are newly identified plasma membrane and mitochondrial ethanolamine transporters","volume":"296","author":"Taylor","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib80","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0021-9258(19)50785-2","article-title":"The function of cytidine coenzymes in the biosynthesis of phospholipides","volume":"222","author":"Kennedy","year":"1956","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib81","doi-asserted-by":"crossref","first-page":"9626","DOI":"10.1073\/pnas.1001292107","article-title":"Induced polymerization of mammalian acetyl-CoA carboxylase by MIG12 provides a tertiary level of regulation of fatty acid synthesis","volume":"107","author":"Kim","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib82","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1194\/jlr.M072512","article-title":"Long-chain acyl-CoA synthetase isoforms differ in preferences for eicosanoid species and long-chain fatty acids","volume":"58","author":"Klett","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib83","doi-asserted-by":"crossref","first-page":"21431","DOI":"10.1074\/jbc.M201708200","article-title":"Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics","volume":"277","author":"Daugherty","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib84","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1432-1033.1996.0186r.x","article-title":"Biochemical studies of two rat acyl-CoA synthetases, ACS1 and ACS2","volume":"242","author":"Iijima","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jlr.2024.100555_bib85","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/oxfordjournals.jbchem.a022165","article-title":"A\u00a0novel acyl-CoA synthetase, ACS5, expressed in intestinal epithelial cells and proliferating preadipocytes","volume":"124","author":"Oikawa","year":"1998","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.jlr.2024.100555_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.phytochem.2003.10.017","article-title":"Eicosapentaenoic acid: biosynthetic routes and the potential for synthesis in transgenic plants","volume":"65","author":"Sayanova","year":"2004","journal-title":"Phytochemistry"},{"key":"10.1016\/j.jlr.2024.100555_bib87","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1073\/pnas.1302961110","article-title":"Label-free quantitative proteomics of the lysine acetylome in mitochondria identifies substrates of SIRT3 in metabolic pathways","volume":"110","author":"Rardin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jlr.2024.100555_bib88","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","article-title":"Comparative lipidomic analysis of mouse and human brain with Alzheimer disease","volume":"287","author":"Chan","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101223","article-title":"Systematic review of brain and blood lipidomics in Alzheimer's disease mouse models","volume":"90","author":"Ferr\u00e9-Gonz\u00e1lez","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib91","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fnmol.2020.00058","article-title":"Lysophospholipids and their G-coupled protein signaling in Alzheimer's disease: from physiological performance to pathological impairment","volume":"13","author":"Hao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib92","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1194\/jlr.M057869","article-title":"Global changes of phospholipids identified by MALDI imaging mass spectrometry in a mouse model of Alzheimer's disease","volume":"57","author":"Hong","year":"2016","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib94","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1194\/jlr.R046094","article-title":"Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells","volume":"55","author":"Hishikawa","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.jlr.2024.100555_bib95","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.337","article-title":"The Kennedy pathway\u2014de novo synthesis of phosphatidylethanolamine and phosphatidylcholine","volume":"62","author":"Gibellini","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jlr.2024.100555_bib96","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"Glozak","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.jlr.2024.100555_bib97","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jlr.2024.100555_bib98","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/genes14020347","article-title":"Histone modifications in Alzheimer\u2019s disease","volume":"14","author":"Santana","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jlr.2024.100555_bib99","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ibra.12106","article-title":"Aging-related histone modification changes in brain function","volume":"9","author":"Ding","year":"2023","journal-title":"Ibrain"},{"key":"10.1016\/j.jlr.2024.100555_bib100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?","volume":"8","author":"Simoes-Pires","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jlr.2024.100555_bib101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/417455a","article-title":"HDAC6 is a microtubule-associated deacetylase","volume":"417","author":"Hubbert","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jlr.2024.100555_bib102","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1074\/jbc.274.4.2440","article-title":"Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers","volume":"274","author":"Verdel","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126592","article-title":"Quantification of histone deacetylase isoforms in human frontal cortex, human retina, and mouse brain","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jlr.2024.100555_bib104","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1091\/mbc.e09-03-0200","article-title":"RhoG promotes neural progenitor cell proliferation in mouse cerebral cortex","volume":"20","author":"Fujimoto","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jlr.2024.100555_bib105","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-4598-11-65","article-title":"The small GTPase RhoG mediates glioblastoma cell invasion","volume":"11","author":"Kwiatkowska","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jlr.2024.100555_bib106","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3324\/haematol.2018.210286","article-title":"ARHGEF12 regulates erythropoiesis and is involved in erythroid regeneration after chemotherapy in acute lymphoblastic leukemia patients","volume":"105","author":"Xie","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jlr.2024.100555_bib107","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1091\/mbc.e10-12-0936","article-title":"The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading","volume":"22","author":"Doherty","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jlr.2024.100555_bib108","first-page":"4602","article-title":"GRAF1a is a brain-specific protein that promotes lipid droplet clustering and growth, and is enriched at lipid droplet junctions","volume":"127","author":"Lucken-Ardjomande H\u00e4sler","year":"2014","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib109","doi-asserted-by":"crossref","first-page":"14134","DOI":"10.1523\/JNEUROSCI.1711-10.2010","article-title":"Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins","volume":"30","author":"Oh","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jlr.2024.100555_bib110","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s00018-019-03050-3","article-title":"Rab18: new insights into the function of an essential protein","volume":"76","author":"Dejgaard","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib111","article-title":"Rab18 binds PLIN2 and ACSL3 to mediate lipid droplet dynamics","volume":"1866","author":"Deng","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jlr.2024.100555_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105295","article-title":"Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis","volume":"299","author":"Kiss","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jlr.2024.100555_bib113","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1242\/jcs.01660","article-title":"The Ras superfamily at a glance","volume":"118","author":"Wennerberg","year":"2005","journal-title":"J.\u00a0Cell. Sci."},{"key":"10.1016\/j.jlr.2024.100555_bib114","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.3390\/ijms23073706","article-title":"Small-molecule RAS inhibitors as anticancer agents: discovery, development, and mechanistic studies","volume":"23","author":"Shetu","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227524000609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T05:03:22Z","timestamp":1719551002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227524000609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":114,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0022227524000609"],"URL":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100555","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unbiased insights into the multiplicity of the CYP46A1 brain effects in 5XFAD mice treated with low dose-efavirenz","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jlr.2024.100555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100555"}}